LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action

Author： Limonta P. Marelli M.M. Moretti R.M.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.4, 2001-04, pp. : 709-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rebeccamycin analogues as anti-cancer agents

By Prudhomme M.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 123-140

Elsevier

Access to resources Recommend Favorite

Microtubulin Binding Sites as Target for Developing Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-12 ,pp. : 1077-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues

Current Medicinal Chemistry, Vol. 24, Iss. 42, 2018-01 ,pp. : 4779-4799

Bentham Science Publishers

Access to resources Recommend Favorite

Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents

By Casini Angela Scozzafava Andrea Supuran Claudiu T

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 9, 2002-09 ,pp. : 1307-1327

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

By Kiaris Hippokratis Koutsilieris Michael Kalofoutis Anastasios Schally Andrew V

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite